SIGA Technologies
SIGA
#8825
Rank
โ‚น21.22 B
Marketcap
โ‚น295.37
Share price
1.45%
Change (1 day)
-48.81%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น0.98 Billion

According to SIGA Technologies's latest financial reports the company's total liabilities are โ‚น0.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น4.78 B132.52%
2022-12-31โ‚น2.05 B-31.56%
2021-12-31โ‚น3.00 B105.25%
2020-12-31โ‚น1.46 B-79.61%
2019-12-31โ‚น7.18 B2.24%
2018-12-31โ‚น7.02 B-76.47%
2017-12-31โ‚น29.86 B-1.97%
2016-12-31โ‚น30.47 B-2.48%
2015-12-31โ‚น31.24 B21.06%
2014-12-31โ‚น25.80 B136.23%
2013-12-31โ‚น10.92 B157.17%
2012-12-31โ‚น4.24 B61.89%
2011-12-31โ‚น2.62 B291.41%
2010-12-31โ‚น0.67 B-22.98%
2009-12-31โ‚น0.87 B150.08%
2008-12-31โ‚น0.34 B65.48%
2007-12-31โ‚น0.21 B-29.59%
2006-12-31โ‚น0.29 B131.02%
2005-12-31โ‚น0.12 B92.5%
2004-12-31โ‚น67.18 M169.16%
2003-12-31โ‚น24.96 M-20.76%
2002-12-31โ‚น31.5 M-2%
2001-12-31โ‚น32.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น155.97 B 15,797.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น107.65 B 10,873.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น6.36 B 548.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.11 B-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น95.05 B 9,589.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น72.82 B 7,322.79%๐Ÿ‡บ๐Ÿ‡ธ USA